Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for Postoperative Stroke Prevention in Brain Tumor Resection
NCT07520370Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2029
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised, double-blind trial in stroke comparing Ulinastatin group with Placebo group (2 arms). Primary endpoint: Incidence of postoperative stroke at 7 days. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
ulinastatin
03
Conditions
stroke
Beyond the preview
Go deeper on NCT07520370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07520370.